IMARA Inc.
PDE9 INHIBITORS FOR TREATING THALASSEMIA
Last updated:
Abstract:
The present disclosure relates to PDE9 inhibitors, compositions comprising the PDE9 inhibitors, and methods of using the PDE9 inhibitors and compositions for treatment of thalassemia.
Status:
Application
Type:
Utility
Filling date:
29 Oct 2021
Issue date:
17 Feb 2022